Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Moukhine A, Rollot F, Casey R, Collongues N, Vukusic S, Mathey G, Dubessy AL, Ciron J, De Seze J, Ruet A, Labauge P, Kwiatkowski A, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Laplaud DA, Berger E, Thouvenot E, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, Magy L, Camdessanché JP, Doghri I, Moulin S, Rivière MS, Hankiewicz K, Santos AD, Pottier C, Manchon E, Aboab J, Tchikviladze M, David T, Edan G, Le Page E, Michel L, Kerbrat A, OFSEP Investigators

Open source

DOI: 10.1002/acn3.70497
Published: 2026 Aug 13
Container: Annals of clinical and translational neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/acn3.70497,
  title = {Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.},
  author = {Moukhine A and Rollot F and Casey R and Collongues N and Vukusic S and Mathey G and Dubessy AL and Ciron J and De Seze J and Ruet A and Labauge P and Kwiatkowski A and Zephir H and Papeix C and Defer G and Lebrun-Frenay C and Laplaud DA and Berger E and Thouvenot E and Pelletier J and Al Khedr A and Casez O and Bourre B and Wahab A and Magy L and Camdessanché JP and Doghri I and Moulin S and Rivière MS and Hankiewicz K and Santos AD and Pottier C and Manchon E and Aboab J and Tchikviladze M and David T and Edan G and Le Page E and Michel L and Kerbrat A and OFSEP Investigators},
  year = {2026},
  journal = {Annals of clinical and translational neurology},
  doi = {10.1002/acn3.70497},
  url = {https://doi.org/10.1002/acn3.70497}
}

RIS

TY  - JOUR
TI  - Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.
AU  - Moukhine A
AU  - Rollot F
AU  - Casey R
AU  - Collongues N
AU  - Vukusic S
AU  - Mathey G
AU  - Dubessy AL
AU  - Ciron J
AU  - De Seze J
AU  - Ruet A
AU  - Labauge P
AU  - Kwiatkowski A
AU  - Zephir H
AU  - Papeix C
AU  - Defer G
AU  - Lebrun-Frenay C
AU  - Laplaud DA
AU  - Berger E
AU  - Thouvenot E
AU  - Pelletier J
AU  - Al Khedr A
AU  - Casez O
AU  - Bourre B
AU  - Wahab A
AU  - Magy L
AU  - Camdessanché JP
AU  - Doghri I
AU  - Moulin S
AU  - Rivière MS
AU  - Hankiewicz K
AU  - Santos AD
AU  - Pottier C
AU  - Manchon E
AU  - Aboab J
AU  - Tchikviladze M
AU  - David T
AU  - Edan G
AU  - Le Page E
AU  - Michel L
AU  - Kerbrat A
AU  - OFSEP Investigators
PY  - 2026
JO  - Annals of clinical and translational neurology
DO  - 10.1002/acn3.70497
UR  - https://doi.org/10.1002/acn3.70497
ER  -

APA

A, M., F, R., R, C., N, C., S, V., G, M., AL, D., J, C., J, D. S., A, R., P, L., A, K., H, Z., C, P., G, D., C, L., DA, L., E, B., E, T., J, P., A, A. K., O, C., B, B., A, W., L, M., JP, C., I, D., S, M., MS, R., K, H., AD, S., C, P., E, M., J, A., M, T., T, D., G, E., E, L. P., L, M., A, K., & Investigators, O. (2026). Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.70497

Source records

pubmed · retrieved 2026-09-25T05:47:01.767Z